High interleukin-12 production from stimulated peripheral blood mononuclear cells of type 2 diabetes patients
- 30 September 2010
- journal article
- Published by Elsevier BV in Cytokine
- Vol. 51 (3), 298-304
- https://doi.org/10.1016/j.cyto.2010.06.014
Abstract
No abstract availableKeywords
Funding Information
- Chang Gung Memorial Hospital (CMRPG260541)
This publication has 18 references indexed in Scilit:
- Interleukin-12 Is the Optimum Cytokine To Expand Human Th17 Cells In VitroClinical and Vaccine Immunology, 2009
- Blood glucose control in patients with severe sepsis and septic shockWorld Journal of Gastroenterology, 2009
- IL-12 serum levels in patients with type 2 diabetes treated with sulphonylureasCytokine, 2008
- TH-17 cells in the circle of immunity and autoimmunityNature Immunology, 2007
- Control of immune responses by immunoregulatory T cellsArchivum Immunologiae et Therapiae Experimentalis, 2006
- Acute Hyperinsulinemia Restrains Endotoxin-induced Systemic Inflammatory ResponseAnesthesiology, 2004
- Activation and Repression of Interleukin-12 p40 Transcription by Erythroid Kruppel-like Factor in MacrophagesPublished by Elsevier BV ,2004
- Nitric Oxide Mediates the Antiapoptotic Effect of Insulin in Myocardial Ischemia-ReperfusionCirculation, 2002
- Intensive Insulin Therapy in Critically Ill PatientsNew England Journal of Medicine, 2001
- Increased In Vitro Interleukin-12 Production by Peripheral Blood in High-Risk IDDM First Degree RelativesHormone and Metabolic Research, 1997